Clinical Trial Detail

NCT ID NCT03069950
Title Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

colorectal adenocarcinoma

Therapies

Floxiuridine + Panitumumab + Dexamethasone + FOLFIRI

Age Groups: senior adult

Additional content available in CKB BOOST